BioElectronics innovative medical devices safely and effectively treat chronic and acute pain through a unique mechanism of non-invasive sub-sensory neuromodulation.

BioElectronics Regulatory Logos

  • FDA market clearance for over the counter use for the treatment of musculoskeletal pain
  • FDA market clearance for prescription use for the treatment of postoperative pain
  • ISO Certification
  • CE Mark (Renewal Pending)
  • HealthCanada
  • UK National Health Service Reimbursement

Chronic Pain & Central Sensitization

Chronic Pain & Central Sensitization Illustration 12-14-15Chronic pain results from central sensitization, which causes the nervous system to develop a persistent state of high reactivity. This serves to amplify and maintain the pain even after the initial injury has healed.

Therefore, chronic pain is often poorly correlated to the degree of peripheral tissue injury. ActiPatch’s electromagnetic signal pulses 1,000 times per second to stimulate neuromodulation of the afferent nerves to dampen the brains perception of pain.

The ActiPatch pulsed signal rate prevents adaption to allow long-term use. ActiPatch therapy extended pain relief improves sleep, physical activity and overall quality of life.